FGFR3 and adenocarcinoma: In a previous study that analyzed RNA sequencing data from 4366 primary tumor samples across 13 tumor types, the FGFR3-TACC3 fusion was detected more frequently in squamous cell carcinoma than adenocarcinoma (Tamura 2018).